Levetiracetam
Product Images NDC 65977-5039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 65977-5039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hetero Drugs Ltd.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 mg (30s count)

1000 mg (30s count)
This is a description of a medication called Levetiracetam that comes in tablet form and is sold in a package containing 30 tablets. The recommended dosage is not provided. The package includes a serial number and a barcode to identify the product. The manufacturer's name is mentioned as well. No other information about the medication or its usage is provided.*
FDA Label Image

250 mg (30s count)

FDA Label Image

500 mg (30s count)

500 mg (30s count)
The text appears to be a partial product label for a medication called "Levetiracetam" that comes in tablet form. The rest of the text is not available or cannot be read.*
FDA Label Image

750 mg (30s count)

750 mg (30s count)
This document is not readable and appears to be a mix of words and symbols with no coherent meaning. It is therefore not available.*
FDA Label Image

Address (Address.jpg)

Address (Address.jpg)
This text provides information about the manufacturer of a certain product, that is HETERO DRUGS LIMITED with their registration number being 2007370-02. The company's address is mentioned to be at WIO| 22-110, 1D A, Teedimetla, Rev4, Hyderabad – 500 055, India. However, the context of the product or its usage is not mentioned.*
FDA Label Image

Figure 1 (Figure1.jpg)

Figure 1 (Figure1.jpg)
The text "74%, 371%, 298%, Placebo (N=95), Levetiracetam" is not sufficient to generate a useful description. Please provide more context or information.*
FDA Label Image

Figure 2 (Figure2.jpg)

FDA Label Image

Figure 3 (Figure3.jpg)

FDA Label Image

Figure 4 (Figure4.jpg)

Figure 4 (Figure4.jpg)
This appears to be a table or chart showing the percentage of patients in two groups (one with 97 participants and the other with 101) in a medical study who were either given a placebo or the drug levetiracetam. However, without additional context or information, it's difficult to determine the purpose or findings of the study.*
FDA Label Image

Figure 5 (Figure5.jpg)

FDA Label Image

Structure (Structure.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.